Showing results (581-590 of 1,215) with videos related to

Sort By:
Pageof 122
Surgical Case Reports|September 15, 2015
Conservative treatment of idiopathic spontaneous pneumoperitoneum in a bedridden patient: a case reportRyo Tanaka, Hitoshi Kameyama, Masayuki Nagahashi, et al.
Sheng Li Xue Bao : [Acta Physiologica Sinica]|June 21, 2002
[Development and progression in rat brain abnormalities related to early stage of epilepsy measured by magnetic resonance image]Ying Zang, Dan Han, Yun-Huang Yang, et al.
Yi Chuan Xue Bao = Acta Genetica Sinica|July 5, 2002
[Sequence of the ITS region of nuclear ribosomal DNA(nrDNA) in Xinjiang wild Dianthus and its phylogenetic relationship]Lu Zhang, You-Ming Cai, Qiang Zhuge, et al.
Physics in Medicine and Biology|August 31, 2002
Short-scan SPECT imaging with non-uniform attenuation and 3D distance-dependent spatial resolutionXiaochuan Pan, Emil Y Sidky, Chien-Min Kao, et al.
Molecules (Basel, Switzerland)|April 28, 2023
Synthesis and Evaluation of Novel Nitric Oxide-Donating Ligustrazine Derivatives as Potent Antiplatelet Aggregation AgentsHan-Xu Li, Jian-Hui Tian, Hua-Yu Li, et al.
Evolutionary Bioinformatics Online|February 13, 2015
Classification of metagenomics data at lower taxonomic level using a robust supervised classifierTao Hou, Fu Liu, Yun Liu, et al.
Breast Cancer (Tokyo, Japan)|June 5, 2020
Comparison between AJCC 8th prognostic stage and UICC anatomical stage in patients with primary breast cancer: a single institutional retrospective studyRyo Tanaka, Yoji Yamagishi, Tomomi Koiwai, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 10, 2010
The absence of IDO upregulates type I IFN production, resulting in suppression of viral replication in the retrovirus-infected mouseMasato Hoshi, Kuniaki Saito, Akira Hara, et al.
Biochemical and Biophysical Research Communications|December 3, 2024
Oral administration of silicon-based agents attenuates renal fibrosisRyo Tanaka, Yoichi Kakuta, Ryoichi Imamura, et al.
BMC Cancer|July 23, 2022
Neoadjuvant docetaxel, oxaliplatin and S-1 therapy for the patients with large type 3 or type 4 gastric cancer (OGSG1902): protocol of a multi-center, phase II studyShunji Endo, Tetsuji Terazawa, Masahiro Goto, et al.
Pageof 122